Skip to main content
. 2016 Jun 2;2016:9109743. doi: 10.1155/2016/9109743

Table 4.

Association between lincRNA-p21 gene haplotypes with the risk of CAD or MI.

Haplotypea Controls Cases OR (95% CI) P
Number (%) Number (%)
CAD n = 655 n = 615

AAAG 132.99 (10.2) 124.70 (10.1) 1.00 (0.77–1.30) 0.994
GAAG 225.98 (17.3) 171.45 (13.9) 0.78 (0.63–0.97) 0.023b
GAGA 235.99 (18.0) 242.27 (19.7) 1.12 (0.92–1.37) 0.266
GAGG 440.03 (33.6) 421.58 (34.3) 1.04 (0.88–1.22) 0.685
GGGA 274.98 (21.0) 267.15 (21.7) 1.05 (0.87–1.27) 0.633

MI n = 655 n = 279

AAAG 132.99 (10.2) 60.70 (10.9) 1.09 (0.79–1.50) 0.611
GAAG 225.98 (17.3) 69.17 (12.4) 0.68 (0.51–0.91) 0.010b
GAGA 235.99 (18.0) 105.28 (18.9) 1.07 (0.83–1.38) 0.624
GAGG 440.03 (33.6) 195.85 (35.1) 1.08 (0.88–1.33) 0.477
GGGA 274.98 (21.0) 123.87 (22.2) 1.08 (0.85–1.38) 0.521

aThe allelic sequence in the haplotypes is in the following order: rs9380586, rs4713998, rs6930083, rs6931097. Haplotype with frequency less than 3% was pooled and not analyzed.

b P values under 0.05 were shown in bold font.